Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells
| Autor: | Adriana Roman, Perla M. Báez-Vega, Pablo E. Vivas-Mejia, Josean Flores, Ileabett M. Echevarria Vargas, María J. Marcos-Martínez, Fatma Valiyeva, Joel Encarnacion-Rosado |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Adult education cisplatin RBPMS Antineoplastic Agents medicine.disease_cause 03 medical and health sciences Prostate cancer 0302 clinical medicine Cell Line Tumor microRNA medicine Guanine Nucleotide Exchange Factors Humans Neoplasm Invasiveness 3' Untranslated Regions Aged Cell Proliferation Cisplatin Ovarian Neoplasms business.industry Cancer RNA-Binding Proteins Middle Aged medicine.disease humanities 3. Good health microRNAs Cystadenocarcinoma Serous Gene Expression Regulation Neoplastic Repressor Proteins 030104 developmental biology ovarian cancer Oncology 030220 oncology & carcinogenesis Immunology Cancer cell Cancer research MCF-7 Cells miR-21-3p Female Carcinogenesis Ovarian cancer business geographic locations medicine.drug Research Paper |
| Zdroj: | Oncotarget |
| ISSN: | 1949-2553 |
| Popis: | // Perla M. Baez-Vega 1 , Ileabett M. Echevarria Vargas 1, 2 , Fatma Valiyeva 1 , Joel Encarnacion-Rosado 3 , Adriana Roman 3 , Josean Flores 4 , Maria J. Marcos-Martinez 5, 6 , Pablo E. Vivas-Mejia 1, 2 1 Comprehensive Cancer Center, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico 2 Department of Biochemistry, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico 3 Department of Biology, University of Puerto Rico, Rio Piedras Campus, San Juan, Puerto Rico 4 Ponce Health Sciences University, Ponce, Puerto Rico 5 Department of Pathology and Laboratory Medicine-University of Puerto Rico—School of Medicine, San Juan, Puerto Rico 6 Puerto Rico Medical Services Administration, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico Correspondence to: Pablo E. Vivas-Mejia, email: pablo.vivas@upr.edu Keywords: ovarian cancer, microRNAs, miR-21-3p, cisplatin, RBPMS Received: September 01, 2015 Accepted: April 18, 2016 Published: May 07, 2016 ABSTRACT MicroRNA-21 is overexpressed in most cancers and has been implicated in tumorigenesis. Accumulating evidence supports a central role for the miR-21 guide strand (miR-21-5p) in ovarian cancer initiation, progression, and chemoresistance. However, there is limited information regarding the biological role of the miR-21 passenger strand (miR-21-3p) in ovarian cancer cells. The aim of this study was to investigate the role of miR-21-3p and its target genes in cisplatin-resistant ovarian cancer cells. Expression profiling of miR-21-5p and miR-21-3p was performed in a panel of cancer cells by qPCR. Colony formation and invasion assays were carried out on ovarian and prostate cancer cells transfected with miR-21-5p and miR-21-3p inhibitors. Dual luciferase reporter assays were used to identify the miR-21-3p target genes in ovarian cancer cells. Our results show that miR-21-5p had higher expression levels compared to miR-21-3p on a panel of cancer cells. Moreover, inhibition of miR-21-5p or miR-21-3p resulted in a significant decrease in ovarian and prostate cancer cell proliferation and invasion. Luciferase reporter assays identify RNA Binding Protein with Multiple Splicing (RBPMS), Regulator of Chromosome Condensation and POZ Domain Containing Protein 1 (RCBTB1), and Zinc Finger protein 608 (ZNF608) as miR-21-3p target genes. SiRNA-induced RBPMS silencing reduced the sensitivity of ovarian cancer cells to cisplatin treatment. Immunohistochemical analyses of serous ovarian cancer patient samples suggest a significant decrease of RBMPS levels when compared to normal ovarian epithelium. Taken together, the data generated in this study suggests a functional role for miR-21-3p in ovarian cancer and other solid tumors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|